A156100 Stock Overview
A medical company, manufactures and sells spinal implants worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 0/6 |
L&K Biomed Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩6,380.00 |
| 52 Week High | ₩10,950.00 |
| 52 Week Low | ₩5,890.00 |
| Beta | 1.58 |
| 11 Month Change | -21.81% |
| 3 Month Change | -34.90% |
| 1 Year Change | -40.04% |
| 33 Year Change | -60.25% |
| 5 Year Change | n/a |
| Change since IPO | -46.39% |
Recent News & Updates
L&K Biomed Ltd. (KOSDAQ:156100) Investors Are Less Pessimistic Than Expected
Aug 12
Revenues Tell The Story For L&K Biomed Ltd. (KOSDAQ:156100)
Apr 16L&K Biomed (KOSDAQ:156100) Is Making Moderate Use Of Debt
Mar 09
Shareholder Returns
| A156100 | KR Medical Equipment | KR Market | |
|---|---|---|---|
| 7D | -13.6% | -0.07% | -3.5% |
| 1Y | -40.0% | 12.3% | -2.4% |
Return vs Industry: A156100 underperformed the KR Medical Equipment industry which returned 12.3% over the past year.
Return vs Market: A156100 underperformed the KR Market which returned -2.4% over the past year.
Price Volatility
| A156100 volatility | |
|---|---|
| A156100 Average Weekly Movement | 5.1% |
| Medical Equipment Industry Average Movement | 8.0% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in KR Market | 12.0% |
| 10% least volatile stocks in KR Market | 3.4% |
Stable Share Price: A156100's share price has been volatile over the past 3 months.
Volatility Over Time: A156100's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2008 | 60 | Kang guk Jin | www.lnkbiomed.com |
L&K Biomed Ltd., a medical company, manufactures and sells spinal implants worldwide. It offers anterior and expandable lateral lumber cage systems; cervical interbody fusion cage, anterior cervical plate system, posterior cervical fixation system; spinal fixation screw, lumber plate, and spinal fixation systems, as well as posterior lumber interbody cage. The company also provides lateral and anterior lumber interbody cage, and transforaminal lumber interbody cage; MIS spinal and spinal fixation systems; and SI joint fusion system.
L&K Biomed Ltd. Fundamentals Summary
| A156100 fundamental statistics | |
|---|---|
| Market cap | ₩127.20b |
| Earnings (TTM) | ₩664.93m |
| Revenue (TTM) | ₩30.50b |
191.3x
P/E Ratio4.2x
P/S RatioIs A156100 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A156100 income statement (TTM) | |
|---|---|
| Revenue | ₩30.50b |
| Cost of Revenue | ₩4.16b |
| Gross Profit | ₩26.33b |
| Other Expenses | ₩25.67b |
| Earnings | ₩664.93m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 33.35 |
| Gross Margin | 86.35% |
| Net Profit Margin | 2.18% |
| Debt/Equity Ratio | 69.6% |
How did A156100 perform over the long term?
See historical performance and comparison